---
title: "OPENLANE, Inc. (OPLN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/OPLN.US.md"
symbol: "OPLN.US"
name: "OPENLANE, Inc."
industry: "Diversified Support Services"
---

# OPENLANE, Inc. (OPLN.US)

| Item | Detail |
|------|--------|
| Industry | Diversified Support Services |
| Location | US Market |
| Website | [corporate.openlane.com](https://corporate.openlane.com) |

## Company Profile

OPENLANE, Inc., together with its subsidiaries, operates as a digital marketplace for wholesale used vehicles in the United States, Canada, Continental Europe, and the United Kingdom. The company operates through two segments, Marketplace and Finance. The Marketplace segment includes various activit...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-23T04:30:17.000Z

**Overall: D (0.61)**

**Industry**: Diversified Support Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 19 / 25 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.16% |  |
| Net Profit YoY | -309.55% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.45 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3.04B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.93B |  |


**Multi Score**: D

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -7.98% | D |
| Profit Margin | 9.19% | B |
| Gross Margin | 46.15% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 8.16% | B |
| Net Profit YoY | -309.55% | E |
| Total Assets YoY | 2.21% | C |
| Net Assets YoY | -21.72% | E |

#### Cash Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -1876.33% | E |
| OCF YoY | 8.16% | B |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.41 | C |

#### Debt Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 67.60% | D |


```chart-data:radar
{
  "title": "Longbridge Financial Score - OPENLANE, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-7.98%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "9.19%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "46.15%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "8.16%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-309.55%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "2.21%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "-21.72%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "D",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-1876.33%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "8.16%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.41",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "D",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "67.60%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Cintas (US.CTAS) | A | B | A | D | C | B |
| 02 | Copart (US.CPRT) | A | C | C | A | C | B |
| 03 | Brembo (US.BXBLY) | A | C | B | D | C | B |
| 04 | Unifirst (US.UNF) | C | C | A | A | B | B |
| 05 | Healthcare Services (US.HCSG) | C | C | A | B | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -29.52 | 21/21 | 34.57 | 33.74 | 32.86 |
| PB | 2.45 | 10/21 | 2.30 | 2.24 | 2.19 |
| PS (TTM) | 1.57 | 12/21 | 1.72 | 1.68 | 1.63 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-20T05:00:00.000Z

Total Analysts: **9**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 2 | 22% |
| Overweight | 3 | 33% |
| Hold | 4 | 44% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 28.63 |
| Highest Target | 37.00 |
| Lowest Target | 28.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/OPLN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/OPLN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/OPLN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.